This company has been marked as potentially delisted and may not be actively trading. Providence Service (PRSC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock PRSC vs. DGX, LH, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, and YTRAShould you be buying Providence Service stock or one of its competitors? The main competitors of Providence Service include Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Yatra Online (YTRA). Providence Service vs. Quest Diagnostics Laboratory Co. of America DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Yatra Online Providence Service (NASDAQ:PRSC) and Quest Diagnostics (NYSE:DGX) are both consumer discretionary companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, community ranking, risk, earnings and dividends. Do insiders & institutionals have more ownership in PRSC or DGX? 88.1% of Quest Diagnostics shares are owned by institutional investors. 7.5% of Providence Service shares are owned by insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, PRSC or DGX? Quest Diagnostics has higher revenue and earnings than Providence Service. Providence Service is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvidence Service$1.51B0.01$970K$1.650.72Quest Diagnostics$10.16B1.96$871M$7.9122.55 Does the media prefer PRSC or DGX? In the previous week, Quest Diagnostics had 37 more articles in the media than Providence Service. MarketBeat recorded 37 mentions for Quest Diagnostics and 0 mentions for Providence Service. Quest Diagnostics' average media sentiment score of 0.72 beat Providence Service's score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Providence Service Neutral Quest Diagnostics Positive Which has more risk & volatility, PRSC or DGX? Providence Service has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Does the MarketBeat Community prefer PRSC or DGX? Quest Diagnostics received 268 more outperform votes than Providence Service when rated by MarketBeat users. However, 65.71% of users gave Providence Service an outperform vote while only 49.14% of users gave Quest Diagnostics an outperform vote. CompanyUnderperformOutperformProvidence ServiceOutperform Votes27665.71% Underperform Votes14434.29% Quest DiagnosticsOutperform Votes54449.14% Underperform Votes56350.86% Is PRSC or DGX more profitable? Quest Diagnostics has a net margin of 8.80% compared to Providence Service's net margin of 0.23%. Providence Service's return on equity of 17.59% beat Quest Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Providence Service0.23% 17.59% 8.74% Quest Diagnostics 8.80%15.07%6.72% Do analysts prefer PRSC or DGX? Quest Diagnostics has a consensus price target of $185.07, suggesting a potential upside of 3.74%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Quest Diagnostics is more favorable than Providence Service.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Providence Service 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69 SummaryQuest Diagnostics beats Providence Service on 15 of the 19 factors compared between the two stocks. Get Providence Service News Delivered to You Automatically Sign up to receive the latest news and ratings for PRSC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRSC vs. The Competition Export to ExcelMetricProvidence ServiceTransportation Services IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$16.88M$11.89B$7.48B$7.83BDividend YieldN/A4.91%3.39%4.22%P/E Ratio-19.8316.5416.4018.48Price / Sales0.012.607.35103.59Price / Cash32.5425.8516.4234.62Price / Book0.053.214.394.25Net Income$970,000.00$467.60M$260.40M$248.23M Providence Service Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRSCProvidence ServiceN/A$1.19-5.9%N/A-94.7%$16.88M$1.51B-19.833,800Gap UpHigh Trading VolumeDGXQuest Diagnostics4.5578 of 5 stars$161.77-1.2%$181.33+12.1%+29.1%$18.06B$9.87B21.0449,000Analyst ForecastShort Interest ↑LHLaboratory Co. of America4.7184 of 5 stars$212.43-2.2%$268.77+26.5%+19.6%$17.77B$13.01B24.0975,500Earnings ReportAnalyst ForecastShort Interest ↑Positive NewsDVADaVita4.2903 of 5 stars$133.73-4.5%$166.33+24.4%+1.9%$10.70B$12.82B12.4570,000Positive NewsCHEChemed4.5627 of 5 stars$563.30-3.2%$667.00+18.4%+2.0%$8.23B$2.43B28.4614,200Earnings ReportAnalyst ForecastPositive NewsCRVLCorVel0.9416 of 5 stars$110.17-4.3%N/A+36.6%$5.66B$871.31M64.814,230Positive NewsAMEDAmedisys2.8913 of 5 stars$91.83+0.1%$100.75+9.7%+3.1%$3.01B$2.35B36.4420,000Analyst RevisionMDPediatrix Medical Group2.027 of 5 stars$12.04-6.1%$16.75+39.1%+45.7%$1.03B$2.01B-10.037,850Upcoming EarningsPositive NewsAMNAMN Healthcare Services4.2457 of 5 stars$17.84-3.5%$38.67+116.7%-65.9%$681.29M$2.98B-4.634,230Upcoming EarningsAnalyst RevisionCCRNCross Country Healthcare3.6272 of 5 stars$14.13-0.9%$18.41+30.3%-23.0%$463.65M$1.34B-282.542,700Upcoming EarningsAnalyst ForecastNews CoverageYTRAYatra Online2.9996 of 5 stars$0.72+6.4%$3.00+317.2%-53.4%$45.38M$6.79B72.50960Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies DGX Alternatives LH Alternatives DVA Alternatives CHE Alternatives CRVL Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives YTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRSC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Providence Service Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Providence Service With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRSC Stock Free PRSC Stock Alerts